Remote Pharmaceuticals Jobs • Clinical Trials

The Principal Biostatistician will lead and oversee small-to-medium sized and simple-to-high complex Phase I-III clinical trials, providing input to statistical components including protocol, mock shells, SAP text, programmed deliverables and CSR. As a lead biostatistician, you'll oversee statistical activities, review statistical methods, program using SAS and/or R, and prepare research proposals.

The Associate Director provides medical and scientific strategic and operational input into core medical affairs activities including health-care professional and provider interactions, generation of clinical and scientific data, internal and external educational initiatives, and safeguarding patient safety. This position works closely with commercial teams to provide strategic medical input into core brand strategies, marketing activities and market access.

This role provides specialist medical and scientific strategic and operational input into core medical affairs activities, including health-care professional interactions and generation of clinical and scientific data. You will closely with sales, marketing, and commercial teams to provide strategic medical input into core brand strategies, and to support medical affairs and marketing activities.

The Senior Manager Patient Recruitment role serves as the critical link between patients, advocacy groups, and internal clinical teams to ensure that the patient voice is integrated throughout the clinical trial lifecycle. You will be building and maintaining relationships with global and regional patient advocacy groups and individual patient representatives. You will act as the primary point of contact for patient organizations related to clinical trial education and collaboration.

As our Medical Science Liaison (MSL), you’ll be part of our field-based medical team, reporting to the MSL National Field Director, acting as an extension of the Medical Affairs team. You’ll serve as a key scientific resource and expert on cell therapy for both health care professionals (HCPs) and internal stakeholders. Domestic travel of approximately 50-70% will be required.